Retinoic acid suppresses intestinal mucus production and exacerbates experimental enterocolitis
SUMMARY Exposure to retinoids for the treatment of acne has been linked to the etiology of inflammatory bowel disease (IBD). The intestinal mucus layer is an important structural barrier that is disrupted in IBD. Retinoid-induced alteration of mucus physiology has been postulated as a mechanism link...
Saved in:
Main Authors: | Stefan H. Oehlers (Author), Maria Vega Flores (Author), Christopher J. Hall (Author), Kathryn E. Crosier (Author), Philip S. Crosier (Author) |
---|---|
Format: | Book |
Published: |
The Company of Biologists,
2012-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The inflammatory bowel disease (IBD) susceptibility genes NOD1 and NOD2 have conserved anti-bacterial roles in zebrafish
by: Stefan H. Oehlers, et al.
Published: (2011) -
Repositioning drugs for inflammatory disease - fishing for new anti-inflammatory agents
by: Christopher J. Hall, et al.
Published: (2014) -
Modulating intestinal mucus barrier for nanoparticles penetration by surfactants
by: Xin Zhang, et al.
Published: (2019) -
Butyrate suppresses experimental necrotizing enterocolitis-induced brain injury in mice
by: Maribel Martinez, et al.
Published: (2023) -
Eubacterium coprostanoligenes alleviates chemotherapy-induced intestinal mucositis by enhancing intestinal mucus barrier
by: Dongsheng Bai, et al.
Published: (2024)